Guangzhou Boteng Biomedical Technology Co., Ltd.

To evaluate the efficacy and safety of piragrel sodium injection in the treatment of patients with acute ischemic stroke within 48 hours of onset

To evaluate the safety and tolerability of HY-021068 tablets after single or multiple oral administration in healthy Chinese subjects, to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of HY-021068 after single or multiple administration in healthy subjects, and to assess the effect of food on the pharmacokinetics (PK) and pharmacodynamics (PD) of HY-021068

Single-dose tolerability and preliminary PK-PD study of HY-021068 tablets in healthy volunteers